Home LiteratureArticle Details
PMID: 8945532 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

Infection and immunity ·Vol. 64 ·No. 12 ·1996-12-00 ·Pages 4952-9

Egan AM, Gordon DL

Abstract

The mechanism by which Burkholderia pseudomallei is resistant to lysis by human serum is unknown but may include interference with complement activation, effective opsonization, or complement-mediated lysis. We investigated the interaction of B. pseudomallei with complement in the presence and absence of specific antibody to determine potential mechanisms of serum resistance. We demonstrated rapid activation and consumption of complement by B. pseudomallei which, in the absence of specific antibody, occurred predominantly via the alternative pathway. Complement activation was associated with deposition of the opsonically active C3b and iC3b fragments on the bacterial surface. C5b-9, detected on the bacterial surface after opsonic periods of 1 to 60 min, was susceptible to elution by 1 M NaCl, indicating that resistance to complement-mediated lysis may result from deposition of the membrane attack complex in a nonmicrobicidal location. To define the role of opsonins, we investigated the ability of polymorphonuclear leukocytes (PMNL) to phagocytose B. pseudomallei. Phagocytosis of bacteria by PMNL, and the observed oxidative response, was significantly increased by opsonization of organisms with complement and/or specific antibody. Despite opsonophagocytosis by PMNL and the production of an oxidative response, no significant bacterial killing was observed.

MeSH Terms
Burkholderia pseudomallei Complement Activation Humans Melioidosis/blood,microbiology Neutrophils/microbiology Opsonin Proteins Phagocytosis
Chemicals
Opsonin Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Egan A M
Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, South Australia.
Gordon D L
References (39)
39 references, click to expand
  1. The prevalence of human melioidosis in Northern Queensland.
    Am J Trop Med Hyg. 1984 May;33(3):474-8 PMID: 6731680
  2. Relapse in melioidosis: incidence and risk factors.
    J Infect Dis. 1993 Nov;168(5):1181-5 PMID: 8228352
  3. Intracellular survival of Burkholderia pseudomallei.
    Infect Immun. 1996 Mar;64(3):782-90 PMID: 8641782
  4. Complement evasion by bacteria and parasites.
    Annu Rev Microbiol. 1988;42:201-30 PMID: 3059994
  5. Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.
    J Immunol Methods. 1977;14(3-4):303-11 PMID: 839081
  6. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.
    Infect Immun. 1992 Jan;60(1):189-95 PMID: 1729182
  7. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
  8. Interaction of insulin with Pseudomonas pseudomallei.
    Infect Immun. 1993 Oct;61(10):4045-50 PMID: 7691742
  9. Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages.
    Infect Immun. 1991 Aug;59(8):2645-52 PMID: 1906842
  10. Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.
    J Infect Dis. 1989 Aug;160(2):253-60 PMID: 2760482
  11. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
    J Clin Invest. 1990 Apr;85(4):1304-14 PMID: 2138634
  12. Strategies of obligate intracellular parasites for evading host defences.
    Immunol Today. 1991 Mar;12(3):A22-7 PMID: 2069674
  13. Halving of mortality of severe melioidosis by ceftazidime.
    Lancet. 1989 Sep 23;2(8665):697-701 PMID: 2570956
  14. Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.
    J Clin Invest. 1992 Sep;90(3):953-64 PMID: 1522243
  15. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
    J Immunol. 1990 Apr 1;144(7):2771-80 PMID: 2108212
  16. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.
    Chest. 1975 Aug;68(2):261-3 PMID: 1149556
  17. Human melioidosis. A histopathologic study of acute and chronic melioidosis.
    Arch Pathol. 1970 Aug;90(2):101-11 PMID: 5433595
  18. Survival of Pseudomonas pseudomallei in human phagocytes.
    J Med Microbiol. 1990 Feb;31(2):109-14 PMID: 2304065
  19. Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis.
    J Clin Microbiol. 1993 Jun;31(6):1592-6 PMID: 7686185
  20. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors.
    J Exp Med. 1987 Nov 1;166(5):1377-89 PMID: 3316470
  21. Resistance of Pseudomonas pseudomallei to normal human serum bactericidal action.
    Microbiol Immunol. 1988;32(7):645-52 PMID: 3193910
  22. Identification of Pseudomonas pseudomallei in the clinical laboratory.
    J Clin Pathol. 1979 May;32(5):500-4 PMID: 381328
  23. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
    J Infect Dis. 1988 Apr;157(4):697-704 PMID: 3279137
  24. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  25. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes.
    J Infect Dis. 1986 Oct;154(4):619-26 PMID: 2943825
  26. The histopathology of human melioidosis.
    Histopathology. 1995 Jan;26(1):51-5 PMID: 7713483
  27. Aeromonas salmonicida resistance to complement-mediated killing.
    Infect Immun. 1994 Dec;62(12):5483-90 PMID: 7525485
  28. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    J Exp Med. 1982 Mar 1;155(3):809-19 PMID: 6801180
  29. Melioidosis: review and update.
    Rev Infect Dis. 1989 May-Jun;11(3):413-25 PMID: 2665001
  30. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    J Exp Med. 1982 Mar 1;155(3):797-808 PMID: 6801179
  31. Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
    Infect Immun. 1986 Dec;54(3):689-94 PMID: 3096887
  32. Comparative biology of intracellular parasitism.
    Microbiol Rev. 1985 Sep;49(3):298-337 PMID: 3900672
  33. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
    J Immunol. 1992 Feb 1;148(3):827-36 PMID: 1730875
  34. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens.
    Pathology. 1979 Apr;11(2):293-7 PMID: 460953
  35. Melioidosis: pathogenesis and immunity in mice and hamsters. I. Studies with virulent strains of Malleomyces pseudomallei.
    J Exp Med. 1958 Jan 1;107(1):153-66 PMID: 13481262
  36. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo.
    J Immunol. 1986 Jan;136(2):710-5 PMID: 2416822
  37. Melioidosis: the tip of the iceberg?
    Clin Microbiol Rev. 1991 Jan;4(1):52-60 PMID: 2004347
  38. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
    J Immunol. 1979 May;122(5):1994-9 PMID: 376729
  39. Complement and bacteria: chemistry and biology in host defense.
    Annu Rev Immunol. 1984;2:461-91 PMID: 6399850
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1996-12-00
Pages
4952-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC174474
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com